|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions increases expression |
ISO |
dihydroouabain promotes the reaction [RORC protein binds to G6PC1 promoter] dihydroouabain results in increased expression of G6PC1 mRNA |
CTD |
PMID:29981919 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
dihydroouabain results in increased expression of and results in increased secretion of IL17A protein |
CTD |
PMID:29981919 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il17f |
interleukin 17F |
multiple interactions |
ISO |
dihydroouabain results in increased expression of and results in increased secretion of IL17F protein |
CTD |
PMID:29981919 |
|
NCBI chr 9:23,190,094...23,201,482
Ensembl chr 9:23,190,100...23,201,482
|
|
G |
Npas2 |
neuronal PAS domain protein 2 |
increases expression multiple interactions |
ISO |
dihydroouabain results in increased expression of NPAS2 mRNA dihydroouabain promotes the reaction [RORC protein binds to NPAS2 promoter] |
CTD |
PMID:29981919 |
|
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
|
|
G |
Rorc |
RAR-related orphan receptor C |
multiple interactions increases expression |
ISO |
dihydroouabain promotes the reaction [RORC protein binds to G6PC1 promoter]; dihydroouabain promotes the reaction [RORC protein binds to NPAS2 promoter]; RORC protein promotes the reaction [dihydroouabain results in increased expression of RORC mRNA] |
CTD |
PMID:29981919 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
|
G |
Acrbp |
acrosin binding protein |
increases expression |
ISO |
erastin results in increased expression of ACRBP mRNA alternative form |
CTD |
PMID:35234341 |
|
NCBI chr 4:157,851,149...157,864,211
Ensembl chr 4:157,841,841...157,864,213
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
EXP |
erastin results in increased expression of ATG5 protein |
CTD |
PMID:32937103 |
|
NCBI chr20:47,798,222...47,889,216
Ensembl chr20:47,798,290...47,889,209
|
|
G |
Bgn |
biglycan |
multiple interactions decreases expression |
ISO |
BGN mRNA alternative form inhibits the reaction [erastin results in decreased expression of MKI67 protein]; erastin inhibits the reaction [[Antineoplastic Agents, Immunological results in decreased susceptibility to Antineoplastic Agents, Immunological] which results in increased expression of BGN mRNA alternative form] erastin results in decreased expression of BGN mRNA alternative form |
CTD |
PMID:35234341 |
|
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
|
|
G |
Chac1 |
ChaC glutathione-specific gamma-glutamylcyclotransferase 1 |
multiple interactions increases expression |
ISO |
GW 506033X inhibits the reaction [erastin results in increased expression of CHAC1 mRNA] |
CTD |
PMID:30817950 |
|
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
increases expression |
ISO |
erastin results in increased expression of COL1A2 mRNA alternative form |
CTD |
PMID:35234341 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
erastin affects the reaction [CYP2E1 protein affects the susceptibility to Ethanol] |
CTD |
PMID:33017621 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
GW 506033X inhibits the reaction [erastin results in increased expression of DDIT3 mRNA] |
CTD |
PMID:30817950 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
increases expression |
ISO |
erastin results in increased expression of DTL mRNA alternative form |
CTD |
PMID:35234341 |
|
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions increases phosphorylation |
ISO |
GW 506033X inhibits the reaction [erastin results in increased phosphorylation of ERN1 protein] |
CTD |
PMID:30817950 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Fancd2 |
FA complementation group D2 |
decreases expression |
EXP |
erastin results in decreased expression of FANCD2 protein |
CTD |
PMID:32937103 |
|
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fh |
fumarate hydratase |
decreases response to substance |
ISO |
FH protein results in decreased susceptibility to erastin |
CTD |
PMID:29917289 |
|
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
|
|
G |
Fth1 |
ferritin heavy chain 1 |
multiple interactions increases expression |
EXP |
3-methyladenine promotes the reaction [erastin results in increased expression of FTH1 protein]; Chloroquine promotes the reaction [erastin results in increased expression of FTH1 protein]; Deferiprone inhibits the reaction [erastin results in increased expression of FTH1 protein]; NFE2L2 protein promotes the reaction [erastin results in increased expression of FTH1 protein] |
CTD |
PMID:32937103 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions increases expression |
EXP |
NFE2L2 protein promotes the reaction [erastin results in increased expression of GCLC protein] |
CTD |
PMID:32937103 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression multiple interactions |
EXP |
erastin results in increased expression of GCLM protein NFE2L2 protein promotes the reaction [erastin results in increased expression of GCLM protein] |
CTD |
PMID:32937103 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
ISO |
GJA1 protein affects the reaction [erastin results in decreased expression of GPX4 protein]; GJA1 protein affects the reaction [erastin results in decreased expression of SLC7A11 protein] |
CTD |
PMID:34785303 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression multiple interactions |
ISO EXP |
erastin results in decreased expression of GPX4 protein gap 27 peptide inhibits the reaction [erastin results in decreased expression of GPX4 protein]; GJA1 protein affects the reaction [erastin results in decreased expression of GPX4 protein]; SESN1 protein inhibits the reaction [erastin results in decreased expression of GPX4 protein] |
CTD |
PMID:31323261 PMID:32937103 PMID:34785303 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
erastin results in increased expression of HMOX1 protein |
CTD |
PMID:30817950 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
increases response to substance |
ISO |
HRAS protein modified form results in increased susceptibility to erastin |
CTD |
PMID:17568748 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
decreases phosphorylation |
EXP |
erastin results in decreased phosphorylation of HSPB1 protein |
CTD |
PMID:32937103 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression multiple interactions |
EXP |
erastin results in increased expression of MAP1LC3B protein modified form 3-methyladenine inhibits the reaction [erastin results in increased expression of MAP1LC3B protein modified form]; Chloroquine promotes the reaction [erastin results in increased expression of MAP1LC3B protein modified form] |
CTD |
PMID:32937103 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
erastin results in increased phosphorylation of MAPK1 protein GW 506033X inhibits the reaction [erastin results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:30817950 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
GW 506033X inhibits the reaction [erastin results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:30817950 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation multiple interactions |
ISO |
erastin results in increased phosphorylation of MAPK8 protein GW 506033X inhibits the reaction [erastin results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:30817950 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression multiple interactions |
ISO |
erastin results in decreased expression of MKI67 protein BGN mRNA alternative form inhibits the reaction [erastin results in decreased expression of MKI67 protein] |
CTD |
PMID:35234341 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Msh2 |
mutS homolog 2 |
increases expression |
ISO |
erastin results in increased expression of MSH2 mRNA alternative form |
CTD |
PMID:35234341 |
|
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Ncoa4 |
nuclear receptor coactivator 4 |
decreases expression multiple interactions |
EXP |
erastin results in decreased expression of NCOA4 protein 3-methyladenine inhibits the reaction [erastin results in decreased expression of NCOA4 protein]; Chloroquine inhibits the reaction [erastin results in decreased expression of NCOA4 protein] |
CTD |
PMID:32937103 |
|
NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,366,542...7,409,641 Ensembl chr16:7,366,542...7,409,641
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases expression |
ISO EXP |
NFE2L2 protein affects the reaction [erastin results in increased expression of SESN2 protein] NFE2L2 protein promotes the reaction [erastin results in increased expression of FTH1 protein]; NFE2L2 protein promotes the reaction [erastin results in increased expression of GCLC protein]; NFE2L2 protein promotes the reaction [erastin results in increased expression of GCLM protein]; NFE2L2 protein promotes the reaction [erastin results in increased expression of SLC7A11 mRNA] erastin results in increased expression of NFE2L2 protein |
CTD |
PMID:31323261 PMID:32937103 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
EXP ISO |
erastin results in increased expression of PTGS2 mRNA erastin analog results in increased expression of PTGS2 mRNA; erastin results in increased expression of PTGS2 mRNA Vitamin E inhibits the reaction [erastin analog results in increased expression of PTGS2 mRNA] |
CTD |
PMID:24439385 PMID:32937103 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Sc5d |
sterol-C5-desaturase |
increases expression |
ISO |
erastin results in increased expression of SC5D mRNA alternative form |
CTD |
PMID:35234341 |
|
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
|
|
G |
Sesn1 |
sestrin 1 |
multiple interactions |
ISO |
SESN1 protein inhibits the reaction [erastin results in decreased expression of GPX4 protein] |
CTD |
PMID:31323261 |
|
NCBI chr20:45,294,876...45,387,698
Ensembl chr20:45,294,871...45,387,697
|
|
G |
Sesn2 |
sestrin 2 |
multiple interactions increases expression |
ISO |
NFE2L2 protein affects the reaction [erastin results in increased expression of SESN2 protein] erastin results in increased expression of SESN2 mRNA; erastin results in increased expression of SESN2 protein Acetylcysteine inhibits the reaction [erastin results in increased expression of SESN2 protein]; Butylated Hydroxyanisole inhibits the reaction [erastin results in increased expression of SESN2 protein]; Dactinomycin inhibits the reaction [erastin results in increased expression of SESN2 mRNA]; Deferoxamine inhibits the reaction [erastin results in increased expression of SESN2 protein]; diphenyleneiodonium inhibits the reaction [erastin results in increased expression of SESN2 protein]; ferrostatin-1 inhibits the reaction [erastin results in increased expression of SESN2 protein]; NFE2L2 protein affects the reaction [erastin results in increased expression of SESN2 protein] |
CTD |
PMID:31323261 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
increases expression |
EXP |
erastin results in increased expression of SLC11A2 protein |
CTD |
PMID:32937103 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc40a1 |
solute carrier family 40 member 1 |
decreases expression increases expression |
EXP ISO |
erastin results in decreased expression of SLC40A1 protein erastin results in increased expression of SLC40A1 protein |
CTD |
PMID:31323261 PMID:32937103 |
|
NCBI chr 9:48,033,526...48,053,876
Ensembl chr 9:48,033,526...48,051,481
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression multiple interactions decreases expression |
EXP ISO |
erastin results in increased expression of SLC7A11 mRNA NFE2L2 protein promotes the reaction [erastin results in increased expression of SLC7A11 mRNA] gap 27 peptide inhibits the reaction [erastin results in decreased expression of SLC7A11 protein]; GJA1 protein affects the reaction [erastin results in decreased expression of SLC7A11 protein] |
CTD |
PMID:32937103 PMID:34785303 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Taf1a |
TATA-box binding protein associated factor, RNA polymerase I subunit A |
decreases expression |
ISO |
erastin results in decreased expression of TAF1A mRNA alternative form |
CTD |
PMID:35234341 |
|
NCBI chr13:95,012,160...95,048,131
Ensembl chr13:95,029,225...95,048,087
|
|
G |
Tf |
transferrin |
increases expression |
EXP |
erastin results in increased expression of TF protein |
CTD |
PMID:32937103 |
|
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
|
|
G |
Tfrc |
transferrin receptor |
increases expression |
EXP ISO |
erastin results in increased expression of TFRC protein |
CTD |
PMID:31323261 PMID:32937103 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
decreases expression |
ISO |
erastin results in decreased expression of TIMP1 mRNA alternative form |
CTD |
PMID:35234341 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Vdac2 |
voltage-dependent anion channel 2 |
decreases expression increases degradation affects binding |
ISO EXP |
erastin results in decreased expression of VDAC2 protein erastin results in increased degradation of VDAC2 protein erastin analog binds to VDAC2 protein |
CTD |
PMID:17568748 PMID:32937103 |
|
NCBI chr15:2,462,877...2,476,802
Ensembl chr15:2,463,056...2,476,553
|
|
G |
Vdac3 |
voltage-dependent anion channel 3 |
increases degradation affects response to substance decreases expression |
EXP ISO |
erastin results in increased degradation of VDAC3 protein VDAC3 protein affects the susceptibility to erastin erastin results in decreased expression of VDAC3 protein |
CTD |
PMID:17568748 PMID:32937103 |
|
NCBI chr16:69,434,982...69,451,473
Ensembl chr16:69,435,005...69,451,471
|
|
G |
Wdr41 |
WD repeat domain 41 |
decreases expression |
ISO |
erastin results in decreased expression of WDR41 mRNA alternative form |
CTD |
PMID:35234341 |
|
NCBI chr 2:26,222,797...26,273,840
Ensembl chr 2:26,224,495...26,273,836
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions decreases response to substance |
ISO |
GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Ethacrynic Acid] |
CTD |
PMID:10900222 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases transport |
ISO |
ABCC2 protein results in increased transport of Ethacrynic Acid |
CTD |
PMID:16316932 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
Ethacrynic Acid results in increased expression of AKR1C1 mRNA |
CTD |
PMID:9973208 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr7a2 |
aldo-keto reductase family 7, member A2 |
multiple interactions |
ISO |
Ethacrynic Acid inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein] |
CTD |
PMID:12604212 |
|
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
increases expression multiple interactions |
ISO |
Ethacrynic Acid results in increased expression of BCL2L1 protein [arsenic trioxide co-treated with Ethacrynic Acid] results in increased expression of BCL2L1 protein |
CTD |
PMID:23082001 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
[arsenic trioxide co-treated with Ethacrynic Acid] results in decreased expression of BIRC5 protein |
CTD |
PMID:23082001 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP3 protein; [MCL1 mutant form results in increased susceptibility to [Ethacrynic Acid co-treated with arsenic trioxide]] which results in increased cleavage of CASP3 protein; GSTP1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP3 protein]; pyrazolanthrone inhibits the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP3 protein] |
CTD |
PMID:23082001 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases cleavage |
ISO |
[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP8 protein Ethacrynic Acid results in increased cleavage of CASP8 protein |
CTD |
PMID:23082001 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases cleavage multiple interactions |
ISO |
Ethacrynic Acid results in increased cleavage of CASP9 protein arsenic trioxide promotes the reaction [Ethacrynic Acid results in increased cleavage of CASP9 protein]; GSTP1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein]; MCL1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein] |
CTD |
PMID:23082001 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
CAT mutant form promotes the reaction [arsenic trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]] |
CTD |
PMID:23082001 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cbr1 |
carbonyl reductase 1 |
multiple interactions |
ISO |
Ethacrynic Acid inhibits the reaction [CBR1 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] |
CTD |
PMID:11306090 |
|
NCBI chr11:32,860,618...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Ethacrynic Acid results in decreased expression of CCND1 mRNA |
CTD |
PMID:20011538 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
Ethacrynic Acid results in increased expression of CDKN1A mRNA |
CTD |
PMID:25817893 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions decreases expression |
ISO |
arsenic trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of CFLAR protein] |
CTD |
PMID:23082001 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO EXP |
Ethacrynic Acid results in increased expression of CYP1A1 mRNA Ethacrynic Acid inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] |
CTD |
PMID:9973208 PMID:18493746 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Ethacrynic Acid results in increased expression of DDIT3 mRNA]; Glutathione inhibits the reaction [Ethacrynic Acid results in increased expression of DDIT3 mRNA] Ethacrynic Acid results in increased expression of DDIT3 mRNA; Ethacrynic Acid results in increased expression of DDIT3 protein |
CTD |
PMID:17171638 PMID:25817893 PMID:35724838 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
ISO |
Ethacrynic Acid results in decreased expression of FN1 mRNA |
CTD |
PMID:20011538 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Ethacrynic Acid results in increased expression of FOS mRNA |
CTD |
PMID:10407097 PMID:12946577 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fzd5 |
frizzled class receptor 5 |
increases expression |
ISO |
Ethacrynic Acid results in increased expression of FZD5 mRNA |
CTD |
PMID:20011538 |
|
NCBI chr 9:66,117,370...66,119,127
Ensembl chr 9:66,113,112...66,121,457
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
ISO |
[GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Ethacrynic Acid |
CTD |
PMID:10900222 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions |
ISO |
[GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Ethacrynic Acid |
CTD |
PMID:10900222 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
decreases response to substance increases expression multiple interactions affects metabolic processing |
ISO EXP |
GSTA1 protein results in decreased susceptibility to Ethacrynic Acid Ethacrynic Acid results in increased expression of GSTA1 mRNA [GSTA1 protein binds to GSTA2 protein] which affects the metabolism of Ethacrynic Acid GSTA1 protein affects the metabolism of Ethacrynic Acid analog |
CTD |
PMID:1985777 PMID:9799558 PMID:9877184 PMID:12781783 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
affects metabolic processing multiple interactions |
EXP |
GSTA2 protein affects the metabolism of Ethacrynic Acid [GSTA1 protein binds to GSTA2 protein] which affects the metabolism of Ethacrynic Acid |
CTD |
PMID:9877184 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
increases expression affects metabolic processing |
EXP |
Ethacrynic Acid results in increased expression of GSTA4 mRNA; Ethacrynic Acid results in increased expression of GSTA4 protein GSTA4 protein affects the metabolism of Ethacrynic Acid |
CTD |
PMID:2619714 PMID:9799558 |
|
NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
affects metabolic processing |
ISO |
GSTM1 protein affects the metabolism of Ethacrynic Acid |
CTD |
PMID:12069689 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases activity affects metabolic processing decreases response to substance increases expression multiple interactions |
ISO EXP |
Ethacrynic Acid analog results in decreased activity of GSTP1 protein; Ethacrynic Acid results in decreased activity of GSTP1 protein GSTP1 protein affects the metabolism of Ethacrynic Acid GSTP1 protein results in decreased susceptibility to Ethacrynic Acid GSTP1 protein affects the metabolism of Ethacrynic Acid analog Ethacrynic Acid results in increased expression of GSTP1 protein Ethacrynic Acid binds to and results in decreased activity of GSTP1 protein; Ethacrynic Acid inhibits the reaction [Chlorophyllides inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]]; Ethacrynic Acid inhibits the reaction [GSTP1 protein affects the metabolism of Isotretinoin]; Ethacrynic Acid inhibits the reaction [GSTP1 protein results in decreased susceptibility to Etoposide]; Ethacrynic Acid inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]; GSTP1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP3 protein]; GSTP1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein]; GSTP1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Ethacrynic Acid]; GSTP1 protein results in decreased susceptibility to [arsenic trioxide co-treated with Ethacrynic Acid]; Pyrimethamine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid]; Quinidine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid]; Quinine inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid]; Tetracycline inhibits the reaction [GSTP1 protein affects the metabolism of and results in decreased activity of Ethacrynic Acid] |
CTD |
PMID:2619714 PMID:2747627 PMID:9463521 PMID:9806904 PMID:9877184 PMID:10900222 PMID:11807801 PMID:12781783 PMID:14556662 PMID:15911318 PMID:15999103 PMID:23082001 PMID:23769903 More...
|
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt2 |
glutathione S-transferase theta 2 |
affects metabolic processing |
EXP |
GSTT2 protein affects the metabolism of Ethacrynic Acid |
CTD |
PMID:2114406 |
|
NCBI chr20:12,819,617...12,823,288
Ensembl chr20:12,819,170...12,823,288
|
|
G |
Gstz1 |
glutathione S-transferase zeta 1 |
affects metabolic processing |
ISO |
GSTZ1 protein affects the metabolism of Ethacrynic Acid |
CTD |
PMID:9396740 |
|
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Ethacrynic Acid results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [Ethacrynic Acid results in increased expression of HMOX1 protein]; Deferoxamine inhibits the reaction [Ethacrynic Acid affects the localization of HMOX1 protein]; Deferoxamine inhibits the reaction [Ethacrynic Acid results in increased expression of HMOX1 mRNA]; Glutathione inhibits the reaction [Ethacrynic Acid results in increased expression of HMOX1 mRNA]; Glutathione inhibits the reaction [Ethacrynic Acid results in increased expression of HMOX1 protein] Ethacrynic Acid results in increased expression of HMOX1 mRNA; Ethacrynic Acid results in increased expression of HMOX1 protein |
CTD |
PMID:20934533 PMID:25817893 PMID:26945724 PMID:35724838 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
increases activity |
ISO |
Ethacrynic Acid results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
Ethacrynic Acid inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; Ethacrynic Acid inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:35724838 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Ethacrynic Acid inhibits the reaction [IL1B protein affects the localization of NFKBIA protein]; Ethacrynic Acid inhibits the reaction [IL1B protein affects the localization of RELA protein]; Ethacrynic Acid inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; Ethacrynic Acid inhibits the reaction [IL1B protein results in increased expression of TNFAIP3 protein] |
CTD |
PMID:35724838 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[Ethacrynic Acid co-treated with arsenic trioxide] results in increased phosphorylation of JUN protein; pyrazolanthrone inhibits the reaction [[Ethacrynic Acid co-treated with arsenic trioxide] results in increased phosphorylation of JUN protein] |
CTD |
PMID:23082001 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
decreases expression affects binding |
ISO |
Ethacrynic Acid results in decreased expression of LEF1 mRNA Ethacrynic Acid binds to LEF1 protein |
CTD |
PMID:20011538 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
increases expression |
ISO |
Ethacrynic Acid results in increased expression of MAP2K1 protein |
CTD |
PMID:14556662 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
decreases expression |
ISO |
Ethacrynic Acid results in decreased expression of MAPK14 protein |
CTD |
PMID:14556662 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases expression |
ISO |
Ethacrynic Acid results in increased expression of MAPK3 protein |
CTD |
PMID:14556662 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
decreases expression |
ISO |
Ethacrynic Acid results in decreased expression of MAPK8 protein |
CTD |
PMID:14556662 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
multiple interactions decreases expression |
ISO |
[MCL1 mutant form results in increased susceptibility to [Ethacrynic Acid co-treated with arsenic trioxide]] which results in increased cleavage of CASP3 protein; Acetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]]; arsenic trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [arsenic trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]]; CAT mutant form promotes the reaction [arsenic trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]]; MCL1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of CASP9 protein]; MCL1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; MCL1 mutant form results in increased susceptibility to [Ethacrynic Acid co-treated with arsenic trioxide]; pyrazolanthrone inhibits the reaction [arsenic trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of MCL1 protein]] |
CTD |
PMID:23082001 |
|
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions affects localization affects response to substance increases expression |
ISO |
NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Ethacrynic Acid] Ethacrynic Acid results in increased expression of and affects the localization of NFE2L2 protein; ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [Ethacrynic Acid affects the localization of NFE2L2 protein]] [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Ethacrynic Acid Ethacrynic Acid results in increased expression of NFE2L2 protein |
CTD |
PMID:19303893 PMID:20932822 PMID:20934533 PMID:25817893 PMID:26945724 PMID:35724838 More...
|
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
Ethacrynic Acid inhibits the reaction [IL1B protein affects the localization of NFKBIA protein]; Ethacrynic Acid inhibits the reaction [TNF protein affects the localization of NFKBIA protein] |
CTD |
PMID:35724838 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Ngf |
nerve growth factor |
increases expression |
ISO |
Ethacrynic Acid results in increased expression of NGF mRNA |
CTD |
PMID:10407097 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
Ethacrynic Acid promotes the reaction [Potassium Cyanide results in increased expression of NOS2 protein] |
CTD |
PMID:16933320 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; GSTP1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; MCL1 mutant form promotes the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein]; pyrazolanthrone inhibits the reaction [[arsenic trioxide co-treated with Ethacrynic Acid] results in increased cleavage of PARP1 protein] |
CTD |
PMID:23082001 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Ethacrynic Acid inhibits the reaction [IL1B protein affects the localization of RELA protein]; Ethacrynic Acid inhibits the reaction [TNF protein affects the localization of RELA protein] |
CTD |
PMID:35724838 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Slc12a2 |
solute carrier family 12 member 2 |
decreases activity multiple interactions |
ISO |
Ethacrynic Acid results in decreased activity of SLC12A2 protein Ethacrynic Acid inhibits the reaction [SLC12A2 protein results in increased uptake of Rubidium] |
CTD |
PMID:29959396 |
|
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
Ethacrynic Acid results in increased expression of SRXN1 protein |
CTD |
PMID:35724838 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Ethacrynic Acid inhibits the reaction [TNF protein affects the localization of NFKBIA protein]; Ethacrynic Acid inhibits the reaction [TNF protein affects the localization of RELA protein]; Ethacrynic Acid inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; Ethacrynic Acid inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein] |
CTD |
PMID:35724838 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
increases expression multiple interactions |
ISO |
Ethacrynic Acid results in increased expression of TNFAIP3 protein Ethacrynic Acid inhibits the reaction [IL1B protein results in increased expression of TNFAIP3 protein]; Ethacrynic Acid inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein] |
CTD |
PMID:35724838 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tp53 |
tumor protein p53 |
affects localization |
ISO |
Ethacrynic Acid affects the localization of TP53 protein |
CTD |
PMID:25817893 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
multiple interactions |
ISO |
[arsenic trioxide co-treated with Ethacrynic Acid] results in decreased expression of XIAP protein |
CTD |
PMID:23082001 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[Metolazone results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA |
CTD |
PMID:25455453 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO |
Metolazone results in increased activity of NR1I2 protein [Metolazone results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA |
CTD |
PMID:25455453 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
|
G |
A2m |
alpha-2-macroglobulin |
affects expression |
ISO |
Ouabain affects the expression of A2M protein |
CTD |
PMID:17268060 |
|
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions increases expression |
ISO |
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Ouabain results in increased expression of ABCB1 protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Ouabain results in increased expression of ABCB1 mRNA]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Ouabain results in increased expression of ABCB1 protein]; [Ouabain results in increased expression of ABCB1] which results in decreased susceptibility to Doxorubicin; KN 93 inhibits the reaction [Ouabain results in increased expression of ABCB1 protein] Ouabain results in increased expression of ABCB1 mRNA; Ouabain results in increased expression of ABCB1 protein |
CTD |
PMID:19647009 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
affects expression |
ISO |
Ouabain affects the expression of ACAA2 protein |
CTD |
PMID:17268060 |
|
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
|
|
G |
Ace |
angiotensin I converting enzyme |
affects expression |
EXP |
Ouabain affects the expression of ACE mRNA; Ouabain affects the expression of ACE protein |
CTD |
PMID:16565308 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
affects expression |
ISO |
Ouabain affects the expression of ACTA2 protein |
CTD |
PMID:17268060 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adh1 |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
affects expression |
ISO |
Ouabain affects the expression of ADH1C protein |
CTD |
PMID:17268060 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Agt |
angiotensinogen |
affects expression increases expression |
EXP |
Ouabain affects the expression of AGT protein Ouabain results in increased expression of AGT protein |
CTD |
PMID:11768735 PMID:16565308 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression affects expression |
EXP |
Ouabain results in decreased expression of AGTR1A protein Ouabain affects the expression of AGTR1A mRNA |
CTD |
PMID:16565308 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases expression |
ISO |
Ouabain results in increased expression of AIFM1 protein |
CTD |
PMID:31436044 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Anxa1 |
annexin A1 |
affects expression |
ISO |
Ouabain affects the expression of ANXA1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Anxa2 |
annexin A2 |
affects expression |
ISO |
Ouabain affects the expression of ANXA2 protein |
CTD |
PMID:17268060 |
|
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
Ouabain results in increased expression of APAF1 protein |
CTD |
PMID:31436044 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Araf |
A-Raf proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
Ouabain results in decreased expression of ARAF mRNA |
CTD |
PMID:16412265 |
|
NCBI chr X:1,227,392...1,292,356
Ensembl chr X:1,227,392...1,239,073
|
|
G |
Arih1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of ARIH1 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 8:59,777,378...59,879,762
Ensembl chr 8:59,777,379...59,880,245
|
|
G |
Arpc5 |
actin related protein 2/3 complex, subunit 5 |
affects expression |
ISO |
Ouabain affects the expression of ARPC5 protein |
CTD |
PMID:17268060 |
|
NCBI chr13:64,904,504...64,913,413
Ensembl chr13:64,887,136...64,913,410
|
|
G |
Arrb1 |
arrestin, beta 1 |
increases expression |
ISO |
Ouabain results in increased expression of ARRB1 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 1:153,837,964...153,912,111
Ensembl chr 1:153,838,078...153,904,061
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
affects expression |
ISO |
Ouabain affects the expression of ASAH1 protein |
CTD |
PMID:17268060 |
|
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
|
|
G |
Atf6b |
activating transcription factor 6 beta |
increases expression |
ISO |
Ouabain results in increased expression of ATF6B protein |
CTD |
PMID:31436044 |
|
NCBI chr20:4,090,921...4,098,920
Ensembl chr20:4,090,921...4,098,894
|
|
G |
Atm |
ATM serine/threonine kinase |
increases phosphorylation |
ISO |
Ouabain results in increased phosphorylation of ATM protein |
CTD |
PMID:31436044 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp12a |
ATPase H+/K+ transporting non-gastric alpha2 subunit |
multiple interactions |
ISO |
Ouabain inhibits the reaction [[ATP12A protein co-treated with ATP4B protein] results in increased uptake of Rubidium] |
CTD |
PMID:8853415 |
|
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions increases expression affects expression affects binding |
ISO EXP |
Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A1 mRNA]; Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A1 protein] Ouabain affects the expression of ATP1A1 protein Ouabain results in increased expression of ATP1A1 mRNA; Ouabain results in increased expression of ATP1A1 protein Ouabain binds to ATP1A1 protein |
CTD |
PMID:11768735 PMID:11834625 PMID:12479229 PMID:16716361 PMID:19995221 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
multiple interactions increases expression decreases expression affects expression decreases activity affects response to substance affects binding |
ISO EXP |
Lithium inhibits the reaction [Ouabain results in increased expression of ATP1A2 mRNA] Ouabain results in increased expression of ATP1A2 protein Ouabain results in decreased expression of ATP1A2 mRNA Ouabain affects the expression of ATP1A2 protein N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in decreased expression of ATP1A2 mRNA] Ouabain results in decreased activity of ATP1A2 protein Ouabain binds to and results in decreased activity of ATP1A2 protein ATP1A2 protein affects the susceptibility to Ouabain Ouabain binds to ATP1A2 protein |
CTD |
PMID:11834625 PMID:12479229 PMID:15458945 PMID:16166162 PMID:16716361 PMID:18487447 PMID:19687166 PMID:19897708 PMID:19995221 More...
|
|
NCBI chr13:84,729,597...84,754,544
Ensembl chr13:84,729,601...84,754,544
|
|
G |
Atp1a3 |
ATPase Na+/K+ transporting subunit alpha 3 |
increases expression multiple interactions decreases expression affects expression affects binding |
ISO EXP |
Ouabain results in increased expression of ATP1A3 mRNA; Ouabain results in increased expression of ATP1A3 protein Potassium Chloride inhibits the reaction [ATP1A3 protein binds to Ouabain] Ouabain results in decreased expression of ATP1A3 mRNA Ouabain affects the expression of ATP1A3 protein N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in decreased expression of ATP1A3 mRNA] ATP1A3 protein binds to Ouabain; Ouabain binds to ATP1A3 protein |
CTD |
PMID:11204457 PMID:12479229 PMID:15276875 PMID:19687166 PMID:19995221 PMID:24631656 More...
|
|
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
|
|
G |
Atp1b1 |
ATPase Na+/K+ transporting subunit beta 1 |
multiple interactions increases expression |
EXP |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Ouabain results in increased expression of ATP1B1 mRNA]; Calcium affects the reaction [Ouabain results in increased expression of ATP1B1 mRNA]; W 7 inhibits the reaction [Ouabain results in increased expression of ATP1B1 mRNA] |
CTD |
PMID:11204457 |
|
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
|
|
G |
Atp4b |
ATPase H+/K+ transporting subunit beta |
multiple interactions |
ISO |
Ouabain inhibits the reaction [[ATP12A protein co-treated with ATP4B protein] results in increased uptake of Rubidium] |
CTD |
PMID:8853415 |
|
NCBI chr16:76,144,150...76,153,063
Ensembl chr16:76,144,150...76,153,063
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
affects expression |
ISO |
Ouabain affects the expression of ATP5F1A protein |
CTD |
PMID:17268060 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atr |
ATR serine/threonine kinase |
decreases phosphorylation |
ISO |
Ouabain results in decreased phosphorylation of ATR protein |
CTD |
PMID:31436044 |
|
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
G |
Bahd1 |
bromo adjacent homology domain containing 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of BAHD1 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 3:105,891,207...105,914,414
Ensembl chr 3:105,892,478...105,914,410
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects localization increases expression multiple interactions |
ISO |
Ouabain affects the localization of BAX protein Ouabain results in increased expression of BAX protein Ouabain inhibits the reaction [HSPD1 protein binds to BAX protein] |
CTD |
PMID:17096883 PMID:18247327 PMID:31436044 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
Ouabain results in decreased expression of BCL2 protein |
CTD |
PMID:31436044 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of BCL2L1 protein |
CTD |
PMID:31436044 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions decreases expression |
EXP |
Lithium inhibits the reaction [Ouabain results in decreased expression of BDNF protein] |
CTD |
PMID:19954800 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
Ouabain results in decreased expression of BRCA1 protein |
CTD |
PMID:31436044 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Calb1 |
calbindin 1 |
decreases expression |
EXP |
Ouabain results in decreased expression of CALB1 protein |
CTD |
PMID:20105455 |
|
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
|
|
G |
Calml5 |
calmodulin-like 5 |
affects expression |
ISO |
Ouabain affects the expression of CALML5 protein |
CTD |
PMID:17268060 |
|
NCBI chr17:66,394,433...66,395,390
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
ISO |
Ouabain results in increased expression of CAMK2B protein |
CTD |
PMID:31436044 |
|
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
|
|
G |
Canx |
calnexin |
increases expression |
ISO |
Ouabain results in increased expression of CANX protein |
CTD |
PMID:18247327 |
|
NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions increases activity |
ISO EXP |
Ouabain results in increased expression of CASP3 protein Ouabain results in increased activity of and results in increased cleavage of CASP3 protein Ouabain results in increased activity of CASP3 protein |
CTD |
PMID:11435898 PMID:17096883 PMID:18247327 PMID:20435043 PMID:31436044 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases expression |
ISO |
Ouabain results in increased expression of CASP4 protein |
CTD |
PMID:31436044 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
Ouabain results in increased expression of and results in increased activity of CASP8 protein |
CTD |
PMID:31436044 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
Ouabain results in increased expression of and results in increased activity of CASP9 protein |
CTD |
PMID:31436044 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity |
EXP |
Lithium inhibits the reaction [Ouabain results in decreased activity of CAT protein]; Valproic Acid inhibits the reaction [Ouabain results in decreased activity of CAT protein] |
CTD |
PMID:20627318 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cav1 |
caveolin 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of CAV1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Ccdc14 |
coiled-coil domain containing 14 |
decreases expression |
ISO |
Ouabain results in decreased expression of CCDC14 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr11:66,052,063...66,087,915
Ensembl chr11:66,052,620...66,087,956
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA]; Amiloride inhibits the reaction [Ouabain results in increased expression of CCL2 protein]; Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 mRNA]; Sodium deficiency inhibits the reaction [Ouabain results in increased expression of CCL2 protein] Ouabain results in increased expression of CCL2 mRNA; Ouabain results in increased expression of CCL2 protein |
CTD |
PMID:11340305 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccna1 |
cyclin A1 |
decreases expression |
ISO |
Ouabain results in decreased expression of CCNA1 mRNA |
CTD |
PMID:20460749 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Ouabain results in decreased expression of CCNA2 mRNA |
CTD |
PMID:21215801 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Ouabain results in decreased expression of CCND1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression increases expression |
ISO |
Ouabain results in decreased expression of CDH1 protein Ouabain results in increased expression of CDH1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of CDH2 mRNA; Ouabain results in decreased expression of CDH2 protein |
CTD |
PMID:28795476 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of CDK2 mRNA; Ouabain results in decreased expression of CDK2 protein |
CTD |
PMID:20460749 PMID:21215801 PMID:31436044 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
Ouabain results in decreased expression of CDK6 protein |
CTD |
PMID:31436044 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression increases expression |
ISO |
Ouabain results in decreased expression of CDKN1A mRNA; Ouabain results in decreased expression of CDKN1A protein Ouabain results in increased expression of CDKN1A mRNA; Ouabain results in increased expression of CDKN1A protein |
CTD |
PMID:20460749 PMID:21215801 PMID:28795476 PMID:31436044 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Ckb |
creatine kinase B |
decreases activity |
EXP |
Ouabain results in decreased activity of CKB protein |
CTD |
PMID:19911114 |
|
NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Cldn1 |
claudin 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of CLDN1 protein |
CTD |
PMID:18247327 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cnpy2 |
canopy FGF signaling regulator 2 |
affects expression |
ISO |
Ouabain affects the expression of CNPY2 protein |
CTD |
PMID:17268060 |
|
NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions increases expression |
EXP |
MIR29B1 mRNA inhibits the reaction [Ouabain results in increased expression of COL1A1 mRNA] |
CTD |
PMID:26702050 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Cs |
citrate synthase |
decreases activity |
EXP |
Ouabain results in decreased activity of CS protein |
CTD |
PMID:20372980 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Cyc1 |
cytochrome c-1 |
multiple interactions |
ISO |
Ouabain results in decreased expression of and affects the localization of CYC1 protein |
CTD |
PMID:18247327 |
|
NCBI chr 7:108,067,106...108,069,483
Ensembl chr 7:108,067,115...108,069,479
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
Ouabain results in increased expression of DDIT3 protein |
CTD |
PMID:31436044 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Ddost |
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit |
decreases expression |
ISO |
Ouabain results in decreased expression of DDOST mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
|
|
G |
Dnaja3 |
DnaJ heat shock protein family (Hsp40) member A3 |
increases expression |
ISO |
Ouabain results in increased expression of DNAJA3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr10:10,855,510...10,880,175
Ensembl chr10:10,854,732...10,880,161
|
|
G |
Drd1 |
dopamine receptor D1 |
multiple interactions decreases expression |
ISO EXP |
Ouabain results in decreased expression of and results in increased phosphorylation of DRD1 protein Ouabain results in increased phosphorylation of and results in decreased expression of DRD1 protein Ouabain results in decreased expression of DRD1 mRNA |
CTD |
PMID:19626329 PMID:20132239 |
|
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
|
|
G |
Dsg1 |
desmoglein 1 |
affects expression |
ISO |
Ouabain affects the expression of DSG1 protein |
CTD |
PMID:17268060 |
|
NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
|
|
G |
Dut |
deoxyuridine triphosphatase |
affects expression |
ISO |
Ouabain affects the expression of DUT protein |
CTD |
PMID:17268060 |
|
NCBI chr 3:112,498,864...112,509,994
Ensembl chr 3:112,498,982...112,510,771
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
increases expression |
ISO |
Ouabain results in increased expression of ECE1 protein |
CTD |
PMID:18247327 |
|
NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
affects expression |
ISO |
Ouabain affects the expression of ECHS1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884
|
|
G |
Edn1 |
endothelin 1 |
increases expression decreases expression |
EXP ISO |
Ouabain results in increased expression of EDN1 mRNA Ouabain results in decreased expression of EDN1 mRNA |
CTD |
PMID:15477225 PMID:28795476 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Ednra |
endothelin receptor type A |
increases expression |
EXP |
Ouabain results in increased expression of EDNRA mRNA; Ouabain results in increased expression of EDNRA protein |
CTD |
PMID:15477225 PMID:16982439 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases phosphorylation |
ISO |
Ouabain results in decreased phosphorylation of EGFR protein |
CTD |
PMID:28795476 |
|
NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases expression |
ISO |
Ouabain results in increased expression of EIF2A protein |
CTD |
PMID:31436044 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
ISO |
Ouabain results in increased expression of and results in increased phosphorylation of EIF2AK3 protein |
CTD |
PMID:31436044 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif3k |
eukaryotic translation initiation factor 3, subunit K |
affects expression |
ISO |
Ouabain affects the expression of EIF3K protein |
CTD |
PMID:17268060 |
|
NCBI chr 1:84,260,125...84,270,051
Ensembl chr 1:84,259,673...84,270,302
|
|
G |
Endog |
endonuclease G |
increases expression |
ISO |
Ouabain results in increased expression of ENDOG protein |
CTD |
PMID:31436044 |
|
NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
decreases expression |
ISO |
Ouabain results in decreased expression of ERCC4 mRNA |
CTD |
PMID:24124520 |
|
NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369
|
|
G |
Ets1 |
ETS proto-oncogene 1, transcription factor |
decreases expression |
ISO |
Ouabain results in decreased expression of ETS1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:31,045,909...31,168,010
Ensembl chr 8:31,045,945...31,168,010
|
|
G |
Fadd |
Fas associated via death domain |
increases expression |
ISO |
Ouabain results in increased expression of FADD protein |
CTD |
PMID:31436044 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fancd2 |
FA complementation group D2 |
multiple interactions decreases expression |
ISO |
Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]; SB 203580 inhibits the reaction [Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCD2 protein]] Ouabain results in decreased expression of FANCD2 mRNA |
CTD |
PMID:24124520 |
|
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fancf |
FA complementation group F |
decreases expression |
ISO |
Ouabain results in decreased expression of FANCF mRNA |
CTD |
PMID:24124520 |
|
NCBI chr 1:101,449,120...101,452,361
Ensembl chr 1:101,450,389...101,451,923
|
|
G |
Fanci |
FA complementation group I |
decreases expression multiple interactions |
ISO |
Ouabain results in decreased expression of FANCI mRNA Ouabain inhibits the reaction [Mitomycin results in increased expression of and affects the ubiquitination of FANCI protein] |
CTD |
PMID:24124520 |
|
NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
|
|
G |
Fars2 |
phenylalanyl-tRNA synthetase 2, mitochondrial |
increases expression |
ISO |
Ouabain results in increased expression of FARS2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr17:28,319,215...28,746,217
Ensembl chr17:28,319,280...28,746,337
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
Ouabain results in increased expression of FAS protein |
CTD |
PMID:31436044 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
ISO |
Ouabain results in increased expression of FASLG protein |
CTD |
PMID:31436044 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fbxo32 |
F-box protein 32 |
multiple interactions |
ISO |
Ouabain affects the reaction [Botulinum Toxins, Type A affects the expression of FBXO32 mRNA] |
CTD |
PMID:21139329 |
|
NCBI chr 7:89,731,626...89,764,761
Ensembl chr 7:89,730,232...89,765,436
|
|
G |
Fh |
fumarate hydratase |
affects expression |
ISO |
Ouabain affects the expression of FH protein |
CTD |
PMID:17268060 |
|
NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
|
|
G |
Fkbp7 |
FKBP prolyl isomerase 7 |
increases expression |
ISO |
Ouabain results in increased expression of FKBP7 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 3:61,609,384...61,623,710
Ensembl chr 3:61,608,557...61,623,280
|
|
G |
Fn1 |
fibronectin 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of FN1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Gc |
GC, vitamin D binding protein |
affects expression |
ISO |
Ouabain affects the expression of GC protein |
CTD |
PMID:17268060 |
|
NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
|
|
G |
Glrb |
glycine receptor, beta |
increases expression |
ISO |
Ouabain results in increased expression of GLRB mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 2:166,134,624...166,207,509
Ensembl chr 2:166,134,626...166,207,489
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of GRB2 protein |
CTD |
PMID:28795476 |
|
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
|
|
G |
Gtpbp6 |
GTP binding protein 6 (putative) |
increases expression |
ISO |
Ouabain results in increased expression of GTPBP6 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr12:46,574,913...46,578,873
Ensembl chr12:46,574,435...46,578,873
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation |
ISO |
Ouabain results in increased phosphorylation of H2AX protein |
CTD |
PMID:31436044 |
|
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hey1 |
hes-related family bHLH transcription factor with YRPW motif 1 |
increases expression |
ISO |
Ouabain results in increased expression of HEY1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 2:93,096,706...93,100,316
Ensembl chr 2:93,095,498...93,100,312
|
|
G |
Hgf |
hepatocyte growth factor |
multiple interactions |
EXP |
Ouabain inhibits the reaction [HGF protein results in increased uptake of estradiol-17 beta-glucuronide] |
CTD |
PMID:18031729 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions affects localization increases activity |
ISO |
2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Ouabain affects the localization of HIF1A protein]; 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate inhibits the reaction [Ouabain results in increased phosphorylation of HIF1A protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Ouabain affects the localization of HIF1A protein]; KN 93 inhibits the reaction [Ouabain affects the localization of HIF1A protein]; KN 93 inhibits the reaction [Ouabain results in increased phosphorylation of HIF1A protein]; Ouabain results in increased phosphorylation of and results in increased expression of HIF1A protein Ouabain results in increased activity of HIF1A protein |
CTD |
PMID:19647009 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
affects expression |
ISO |
Ouabain affects the expression of HNRNPA2B1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
|
|
G |
Hnrnpdl |
heterogeneous nuclear ribonucleoprotein D-like |
decreases expression |
ISO |
Ouabain results in decreased expression of HNRNPDL mRNA |
CTD |
PMID:16412265 |
|
NCBI chr14:9,558,079...9,563,654
Ensembl chr14:9,557,425...9,562,506
|
|
G |
Hpcal1 |
hippocalcin-like 1 |
affects expression |
ISO |
Ouabain affects the expression of HPCAL1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 6:40,478,182...40,584,721
Ensembl chr 6:40,478,208...40,584,687
|
|
G |
Hrg |
histidine-rich glycoprotein |
affects expression |
ISO |
Ouabain affects the expression of HRG protein |
CTD |
PMID:17268060 |
|
NCBI chr11:78,054,488...78,069,402
Ensembl chr11:78,054,498...78,069,389
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO |
Ouabain results in increased expression of HSPA5 protein |
CTD |
PMID:31436044 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
affects expression multiple interactions |
ISO |
Ouabain affects the expression of HSPD1 protein Ouabain inhibits the reaction [HSPD1 protein binds to BAX protein]; Ouabain results in decreased expression of and affects the localization of HSPD1 protein |
CTD |
PMID:17268060 PMID:18247327 |
|
NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
increases expression |
ISO |
Ouabain results in increased expression of ID2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
decreases expression |
ISO |
Ouabain results in decreased expression of IL2RA mRNA |
CTD |
PMID:7593202 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
decreases expression |
ISO |
Ouabain results in decreased expression of IL2RB |
CTD |
PMID:7593202 |
|
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
|
|
G |
Il6 |
interleukin 6 |
increases secretion increases expression |
ISO |
Ouabain results in increased secretion of IL6 protein Ouabain results in increased expression of IL6 mRNA |
CTD |
PMID:33760381 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il6r |
interleukin 6 receptor |
increases expression |
ISO |
Ouabain results in increased expression of IL6R mRNA |
CTD |
PMID:33760381 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Ilk |
integrin-linked kinase |
decreases expression |
ISO |
Ouabain results in decreased expression of ILK mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
|
|
G |
Itgav |
integrin subunit alpha V |
decreases expression |
ISO |
Ouabain results in decreased expression of ITGAV mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 3:68,838,524...68,926,653
Ensembl chr 3:68,838,189...68,926,639
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression decreases phosphorylation |
ISO |
Ouabain results in decreased expression of JUN mRNA Ouabain results in decreased phosphorylation of JUN protein |
CTD |
PMID:28795476 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kcnd2 |
potassium voltage-gated channel subfamily D member 2 |
increases expression |
ISO EXP |
Ouabain results in increased expression of KCND2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 4:49,775,812...50,277,746
Ensembl chr 4:49,776,246...50,277,728
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases expression decreases activity multiple interactions |
ISO |
Ouabain results in decreased expression of KCNH2 protein modified form Ouabain results in decreased activity of KCNH2 protein Ouabain inhibits the reaction [KCNH2 protein results in increased transport of Thallium] |
CTD |
PMID:19139152 PMID:21158687 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of LEF1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Lgals1 |
galectin 1 |
affects expression increases expression |
ISO |
Ouabain affects the expression of LGALS1 protein Ouabain results in increased expression of LGALS1 protein |
CTD |
PMID:17268060 PMID:18247327 |
|
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
|
|
G |
Limk1 |
LIM domain kinase 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of LIMK1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr12:22,026,697...22,060,605
Ensembl chr12:22,026,672...22,060,606
|
|
G |
Lss |
lanosterol synthase |
increases abundance |
ISO |
LSS protein results in increased abundance of Ouabain |
CTD |
PMID:21106941 |
|
NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
increases expression |
ISO |
Ouabain results in increased expression of MAP2K6 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation increases phosphorylation |
EXP ISO |
N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased phosphorylation of MAPK1 protein] Ouabain results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:19687166 PMID:28795476 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation increases phosphorylation |
EXP ISO |
N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased phosphorylation of MAPK3 protein] Ouabain results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:19687166 PMID:28795476 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk7 |
mitogen-activated protein kinase 7 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [palytoxin results in increased phosphorylation of and results in increased activity of MAPK7 protein] |
CTD |
PMID:19716839 |
|
NCBI chr10:46,170,264...46,176,262
Ensembl chr10:46,170,167...46,176,267
|
|
G |
Mdh2 |
malate dehydrogenase 2 |
affects expression |
ISO |
Ouabain affects the expression of MDH2 protein |
CTD |
PMID:17268060 |
|
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions |
ISO |
Ouabain results in decreased expression of and results in decreased phosphorylation of MDM2 protein |
CTD |
PMID:31436044 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
decreases expression |
ISO |
Ouabain results in decreased expression of MGMT protein |
CTD |
PMID:31436044 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mir29b1 |
microRNA 29b-1 |
multiple interactions decreases expression |
EXP |
MIR29B1 mRNA inhibits the reaction [Ouabain results in increased expression of COL1A1 mRNA] Ouabain results in decreased expression of MIR29B1 mRNA |
CTD |
PMID:26702050 |
|
NCBI chr 4:59,650,987...59,651,067
Ensembl chr 4:59,650,986...59,651,067
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
decreases expression |
ISO |
Ouabain results in decreased expression of MMP13 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression multiple interactions |
ISO |
Ouabain results in decreased expression of MMP2 mRNA Ouabain results in decreased expression of and results in decreased activity of MMP2 protein |
CTD |
PMID:28795476 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression |
ISO |
Ouabain results in decreased expression of MMP9 mRNA; Ouabain results in decreased expression of MMP9 protein |
CTD |
PMID:28795476 PMID:33760381 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mras |
muscle RAS oncogene homolog |
decreases expression |
ISO |
Ouabain results in decreased expression of MRAS mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:99,944,036...100,006,771
Ensembl chr 8:99,944,036...99,996,408
|
|
G |
Mrtfa |
myocardin related transcription factor A |
decreases expression |
ISO |
Ouabain results in decreased expression of MRTFA mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 7:112,544,312...112,714,431
Ensembl chr 7:112,544,312...112,714,418
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression increases expression |
ISO |
Ouabain results in decreased expression of MYC mRNA; Ouabain results in decreased expression of MYC protein Ouabain results in increased expression of MYC protein |
CTD |
PMID:9653513 PMID:21215801 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myl12a |
myosin light chain 12A |
increases expression |
ISO |
Ouabain results in increased expression of MYL12A protein |
CTD |
PMID:17268060 |
|
NCBI chr 9:110,891,970...110,899,655
Ensembl chr 9:110,873,959...110,916,580
|
|
G |
Mylk |
myosin light chain kinase |
decreases expression |
ISO |
Ouabain results in decreased expression of MYLK mRNA |
CTD |
PMID:28795476 |
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Nectin3 |
nectin cell adhesion molecule 3 |
decreases expression |
ISO |
Ouabain results in decreased expression of NECTIN3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr11:54,362,712...54,461,316
Ensembl chr11:54,364,487...54,462,519
|
|
G |
Nectin4 |
nectin cell adhesion molecule 4 |
increases expression |
ISO |
Ouabain results in increased expression of NECTIN4 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr13:83,802,589...83,821,711
Ensembl chr13:83,803,184...83,821,709
|
|
G |
Nefl |
neurofilament light chain |
decreases expression |
ISO |
Ouabain results in decreased expression of NEFL mRNA |
CTD |
PMID:28795476 |
|
NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793
|
|
G |
Nos1 |
nitric oxide synthase 1 |
affects expression increases expression |
EXP |
Ouabain affects the expression of NOS1 protein Ouabain results in increased expression of NOS1 protein |
CTD |
PMID:12384489 PMID:15097235 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions affects expression increases expression |
EXP |
5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide inhibits the reaction [Ouabain results in increased expression of NOS3 protein] Ouabain affects the expression of NOS3 protein |
CTD |
PMID:12384489 PMID:15477225 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Npc2 |
NPC intracellular cholesterol transporter 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of NPC2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr 6:104,397,239...104,418,161
Ensembl chr 6:104,378,644...104,418,155
|
|
G |
Nppa |
natriuretic peptide A |
increases expression multiple interactions |
EXP |
Ouabain results in increased expression of NPPA mRNA N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased expression of NPPA mRNA]; Ouabain promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] |
CTD |
PMID:17266992 PMID:19687166 |
|
NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
decreases expression |
ISO |
Ouabain results in decreased expression of NRAS mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
|
|
G |
Park7 |
Parkinsonism associated deglycase |
affects response to substance |
ISO |
PARK7 affects the susceptibility to Ouabain |
CTD |
PMID:16624565 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
Mitomycin promotes the reaction [Ouabain results in increased cleavage of PARP1 protein]; Ouabain promotes the reaction [Mitomycin results in increased cleavage of PARP1 protein] |
CTD |
PMID:24124520 PMID:31436044 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
Ouabain results in decreased expression of PCNA mRNA; Ouabain results in decreased expression of PCNA protein |
CTD |
PMID:20460749 PMID:21215801 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdcd6 |
programmed cell death 6 |
increases expression |
ISO |
Ouabain results in increased expression of PDCD6 protein |
CTD |
PMID:18247327 |
|
NCBI chr 1:28,966,518...28,982,188
Ensembl chr 1:28,966,518...28,982,189
|
|
G |
Pfdn5 |
prefoldin subunit 5 |
affects expression |
ISO |
Ouabain affects the expression of PFDN5 protein |
CTD |
PMID:17268060 |
|
NCBI chr 7:133,451,778...133,456,516
Ensembl chr 7:133,451,453...133,456,516
|
|
G |
Pfn1 |
profilin 1 |
affects expression decreases expression |
ISO |
Ouabain affects the expression of PFN1 protein Ouabain results in decreased expression of PFN1 protein |
CTD |
PMID:17268060 PMID:18247327 |
|
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
decreases expression |
ISO |
Ouabain results in decreased expression of PLAUR mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:80,053,441...80,068,384
Ensembl chr 1:80,050,324...80,068,595
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of PLCG1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Ppt2 |
palmitoyl-protein thioesterase 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of PPT2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr20:4,112,520...4,132,774
Ensembl chr20:4,122,463...4,132,774
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
decreases expression |
ISO |
Ouabain results in decreased expression of PRKDC protein |
CTD |
PMID:31436044 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Psmb6 |
proteasome 20S subunit beta 6 |
affects expression |
ISO |
Ouabain affects the expression of PSMB6 protein |
CTD |
PMID:17268060 |
|
NCBI chr10:55,239,274...55,241,581
Ensembl chr10:55,239,241...55,241,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP |
[Ouabain results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Nitric Oxide |
CTD |
PMID:18976649 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of PTPN2 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
|
|
G |
Rab11b |
RAB11B, member RAS oncogene family |
increases expression |
ISO |
Ouabain results in increased expression of RAB11B protein |
CTD |
PMID:18247327 |
|
NCBI chr 7:14,521,448...14,534,589
Ensembl chr 7:14,521,368...14,534,593
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
Ouabain results in decreased expression of RAF1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of RASGRF1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
|
|
G |
Rgs2 |
regulator of G-protein signaling 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of RGS2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr13:55,799,749...55,802,354
Ensembl chr13:55,798,829...55,802,385
|
|
G |
Rhoh |
ras homolog family member H |
increases expression |
ISO |
Ouabain results in increased expression of RHOH mRNA |
CTD |
PMID:28795476 |
|
NCBI chr14:42,341,135...42,371,971
Ensembl chr14:42,337,751...42,386,369
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
increases cleavage multiple interactions |
ISO |
Ouabain results in increased cleavage of ROCK1 protein benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Ouabain results in increased cleavage of ROCK1 protein] |
CTD |
PMID:20661774 |
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
multiple interactions increases cleavage |
ISO |
benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Ouabain results in increased cleavage of ROCK2 protein] |
CTD |
PMID:20661774 |
|
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
|
|
G |
Rpa3 |
replication protein A3 |
affects expression |
ISO |
Ouabain affects the expression of RPA3 protein |
CTD |
PMID:17268060 |
|
NCBI chr 4:36,304,649...36,307,755
Ensembl chr 4:36,304,651...36,307,709
|
|
G |
Rpgrip1l |
Rpgrip1-like |
decreases expression |
ISO |
Ouabain results in decreased expression of RPGRIP1L mRNA |
CTD |
PMID:16412265 |
|
NCBI chr19:15,692,189...15,785,083
Ensembl chr19:15,692,150...15,785,083
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
affects expression |
EXP |
Ouabain affects the expression of RPS6KB1 mRNA |
CTD |
PMID:28099878 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Ryr2 |
ryanodine receptor 2 |
multiple interactions increases response to substance |
ISO |
K201 compound inhibits the reaction [RYR2 mutant form results in increased susceptibility to Ouabain] |
CTD |
PMID:20080988 |
|
NCBI chr17:58,389,925...58,975,641
Ensembl chr17:58,389,925...58,975,142
|
|
G |
S100a13 |
S100 calcium binding protein A13 |
affects expression |
ISO |
Ouabain affects the expression of S100A13 protein |
CTD |
PMID:17268060 |
|
NCBI chr 2:175,999,439...176,005,933
|
|
G |
S100b |
S100 calcium binding protein B |
increases expression |
EXP |
Ouabain results in increased expression of S100B protein |
CTD |
PMID:15581912 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
multiple interactions decreases expression |
ISO |
Ouabain inhibits the reaction [SGK1 protein results in increased transport of Potassium] Ouabain results in decreased expression of SGK1 mRNA |
CTD |
PMID:12590200 PMID:28795476 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sgk2 |
serum/glucocorticoid regulated kinase 2 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [SGK2 protein results in increased transport of Potassium] |
CTD |
PMID:12590200 |
|
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
|
|
G |
Sgk3 |
serum/glucocorticoid regulated kinase family, member 3 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [SGK3 protein results in increased transport of Potassium] |
CTD |
PMID:12590200 |
|
NCBI chr 5:9,345,761...9,472,243
Ensembl chr 5:9,346,040...9,415,476
|
|
G |
Shc3 |
SHC adaptor protein 3 |
increases expression |
ISO |
Ouabain results in increased expression of SHC3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr17:13,652,247...13,772,710
Ensembl chr17:13,651,202...13,772,710
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] |
CTD |
PMID:15804185 |
|
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
|
|
G |
Slc22a12 |
solute carrier family 22 member 12 |
multiple interactions |
ISO |
Ouabain promotes the reaction [SLC22A12 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:15284287 |
|
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [SLC5A5 protein results in increased uptake of Sodium Iodide] |
CTD |
PMID:12541134 |
|
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
|
|
G |
Slc5a6 |
solute carrier family 5 member 6 |
multiple interactions |
ISO |
Ouabain inhibits the reaction [SLC5A6 protein results in increased transport of Biotin] |
CTD |
PMID:15561972 |
|
NCBI chr 6:25,319,187...25,331,713
Ensembl chr 6:25,320,442...25,331,712
|
|
G |
Slc8a1 |
solute carrier family 8 member A1 |
affects response to substance increases expression multiple interactions |
ISO EXP |
SLC8A1 affects the susceptibility to Ouabain Ouabain results in increased expression of SLC8A1 protein SLC8A1 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of SLC8A1 protein]; SLC8A1 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of TRPC6 protein]; TRPC6 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of SLC8A1 protein] |
CTD |
PMID:16166162 PMID:19897708 |
|
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
multiple interactions increases expression |
EXP |
N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Ouabain results in increased expression of SLC9A1 mRNA] |
CTD |
PMID:19687166 |
|
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
|
|
G |
Smad4 |
SMAD family member 4 |
decreases expression |
ISO |
Ouabain results in decreased expression of SMAD4 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of SNAI1 mRNA |
CTD |
PMID:33760381 |
|
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of SOS1 protein |
CTD |
PMID:28795476 |
|
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
|
|
G |
Sos2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of SOS2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 6:88,042,966...88,156,140
Ensembl chr 6:88,042,966...88,156,692
|
|
G |
Sphk1 |
sphingosine kinase 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of SPHK1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of TGFB1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of TGFB2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfb3 |
transforming growth factor, beta 3 |
decreases expression |
ISO |
Ouabain results in decreased expression of TGFB3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
|
|
G |
Tgfbr3 |
transforming growth factor beta receptor 3 |
increases expression |
ISO |
Ouabain results in increased expression of TGFBR3 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr14:2,489,397...2,665,383
Ensembl chr14:2,489,397...2,663,341
|
|
G |
Tln1 |
talin 1 |
decreases expression |
ISO |
Ouabain results in decreased expression of TLN1 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 5:57,787,670...57,817,900
Ensembl chr 5:57,787,943...57,817,900
|
|
G |
Tln2 |
talin 2 |
decreases expression |
ISO |
Ouabain results in decreased expression of TLN2 mRNA |
CTD |
PMID:28795476 |
|
NCBI chr 8:67,830,920...68,252,223
Ensembl chr 8:67,834,326...68,252,219
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
increases expression |
ISO |
Ouabain results in increased expression of TNFRSF10A protein |
CTD |
PMID:31436044 |
|
NCBI chr15:44,839,818...44,867,582
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
Ouabain results in decreased expression of and results in increased phosphorylation of TP53 protein |
CTD |
PMID:31436044 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
affects expression |
ISO |
Ouabain affects the expression of TPI1 protein |
CTD |
PMID:17268060 |
|
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
|
|
G |
Tpt1 |
tumor protein, translationally-controlled 1 |
affects expression |
ISO |
Ouabain affects the expression of TPT1 protein |
CTD |
PMID:17268060 |
|
NCBI chr15:51,156,728...51,159,629
Ensembl chr15:51,146,154...51,159,625
|
|
G |
Trim63 |
tripartite motif containing 63 |
multiple interactions |
ISO |
[Ouabain co-treated with Botulinum Toxins, Type A] affects the expression of TRIM63 mRNA |
CTD |
PMID:21139329 |
|
NCBI chr 5:146,533,492...146,547,332
Ensembl chr 5:146,533,507...146,547,322
|
|
G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
increases expression |
EXP |
Ouabain results in increased expression of TRPC1 protein |
CTD |
PMID:19897708 |
|
NCBI chr 8:96,263,322...96,314,197
Ensembl chr 8:96,263,329...96,314,276
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
increases expression multiple interactions |
EXP |
Ouabain results in increased expression of TRPC6 protein SLC8A1 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of TRPC6 protein]; TRPC6 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of SLC8A1 protein]; TRPC6 mRNA mutant form inhibits the reaction [Ouabain results in increased expression of TRPC6 protein] |
CTD |
PMID:19897708 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Twist1 |
twist family bHLH transcription factor 1 |
increases expression |
ISO |
Ouabain results in increased expression of TWIST1 mRNA |
CTD |
PMID:33760381 |
|
NCBI chr 6:50,674,910...50,676,904
Ensembl chr 6:50,674,678...50,677,653
|
|
G |
Txn1 |
thioredoxin 1 |
affects expression |
ISO |
Ouabain affects the expression of TXN protein |
CTD |
PMID:17268060 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Vim |
vimentin |
decreases expression |
ISO |
Ouabain results in decreased expression of VIM mRNA |
CTD |
PMID:33760381 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Zfhx3 |
zinc finger homeobox 3 |
decreases expression |
ISO |
Ouabain results in decreased expression of ZFHX3 mRNA |
CTD |
PMID:16412265 |
|
NCBI chr19:36,257,196...36,886,104
Ensembl chr19:36,630,254...36,881,771
|
|